about
HPV-p53-miR-34a axis in HPV-associated cancersInvestigating core genetic-and-epigenetic cell cycle networks for stemness and carcinogenic mechanisms, and cancer drug design using big database mining and genome-wide next-generation sequencing dataNanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitorsEnhanced uptake and transport of PLGA-modified nanoparticles in cervical cancer.MicroRNAs, signaling pathways and diseases.Trends in Biosensors for HPV: Identification and Diagnosis
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Nanotechnology in the management of cervical cancer.
@en
type
label
Nanotechnology in the management of cervical cancer.
@en
prefLabel
Nanotechnology in the management of cervical cancer.
@en
P2093
P2860
P50
P356
P1476
Nanotechnology in the management of cervical cancer.
@en
P2093
P2860
P356
10.1002/RMV.1825
P478
25 Suppl 1
P577
2015-03-01T00:00:00Z